Premium
A prospective study of elective stenting in unprotected left main coronary disease
Author(s) -
Wong Philip,
Wong Vanessa,
Tse KinKee,
Chan Wilson,
Ko Patrick,
Wong ChiMing,
Leung Albert WaiSuen,
Fong PingChing,
Cheng ChunHo,
Tai YauTing,
Leung WingHung,
Liu MeiLin
Publication year - 1999
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/(sici)1522-726x(199902)46:2<153::aid-ccd8>3.0.co;2-7
Subject(s) - medicine , asymptomatic , myocardial infarction , surgery , prospective cohort study , bypass surgery , stent , cause of death , coronary artery disease , thrombosis , cardiology , artery , disease
The standard treatment of left main coronary artery (LMCA) disease has been bypass surgery (CABG). Recent reports suggested that stenting of LMCA disease might be feasible. From January 1995 to April 1998, we carried out a prospective study of elective stenting of unprotected LMCA disease to evaluate its immediate and long‐term results. Of 61 consecutive patients with unprotected LMCA disease, 6 were excluded. Acute procedural success was 100% for the remaining 55 patients, without any complications such as stent thrombosis, myocardial infarction, CABG, or death. During a mean follow‐up of 16.1 ± 9.6 months, 11 patients (20%) had symptomatic recurrence, between 2 to 6 months after their procedure. Seven patients underwent CABG, two had repeat intervention, one continued with medical therapy, and one died before planned angiography. There was no late sudden death. Forty‐four patients (80%) remained asymptomatic. We conclude that elective stenting may be a safe alternative to CABG in unprotected LMCA disease. Cathet. Cardiovasc. Intervent. 46:153–159, 1999. © 1999 Wiley‐Liss, Inc.